<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-3466</journal-id>
<journal-title><![CDATA[Revista Cubana de Salud Pública]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Salud Pública]]></abbrev-journal-title>
<issn>0864-3466</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-34662019000100004</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Consumo de antimicrobianos seleccionados en el Cardiocentro Pediátrico &#8220;William Soler&#8221; durante el periodo 2011-2015]]></article-title>
<article-title xml:lang="en"><![CDATA[Consumption of selected antimicrobials at &#8220;William Soler&#8221; Pediatric Cardiocenter, 2011-2015]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castillo Meriño]]></surname>
<given-names><![CDATA[Damarys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alfonso Orta]]></surname>
<given-names><![CDATA[Ismary]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lambert Maresma]]></surname>
<given-names><![CDATA[José Manuel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Cardiocentro Pediátrico &#8220;William Soler&#8221;  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Centro para el Control de Medicamentos, Equipos y Dispositivos Médicos (CECMED)  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<volume>45</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-34662019000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-34662019000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-34662019000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: El uso irracional de antimicrobianos es un problema de salud. En el Cardiocentro Pediátrico &#8220;William Soler&#8221; existe una amplia utilización de ellos, sin embargo, no se conoce el comportamiento del consumo de este grupo farmacológico en la institución.  Objetivo:  Describir el consumo de antimicrobianos seleccionados en la institución en el periodo 2011-2015.  Método:  Estudio descriptivo, longitudinal del tipo estudio de utilización de medicamentos de consumo de 11 antimicrobianos, de uso restringido y elevado costo (cefepime, meropenem, levofloxacina oral y parenteral, linezolida, teicoplanina, vancomicina, colistina, aztreonam y amoxicilina/sulbactam oral y parenteral). El consumo en unidades físicas se obtuvo a partir de las tarjetas de estiba del almacén de medicamentos de la farmacia intrahospitalaria. Para el cálculo se utilizó la fórmula establecida por la Organización Mundial de la Salud, expresado en dosis diaria definida/100 camas/día (DDD/100 camas/día).  Resultados: Se observó un incremento de 7,28 DDD/100 camas/día, los años 2013 y 2015 se mostraron como los de mayor consumo. Los fármacos más consumidos fueron el meropenem con un incremento de 2,71 DDD/100 camas/día; el cefepime con un incremento de 1,68 DDD/100 camas/día y la linezolida con un aumento de 1,15 DDD/100 camas/día. La terapia 1 y la sala 1A mostraron los mayores valores de consumo.  Conclusiones: Los antimicrobianos han reducido de manera importante la amenaza de enfermedades infecciosas y son una herramienta indispensable en el tratamiento de los pacientes en los hospitales. El consumo de antimicrobianos seleccionados en el Cardiocentro Pediátrico &#8220;William Soler&#8221;, considerados de alto costo y utilización restringida, evidencia una tendencia al incremento, lo cual muestra la necesidad de desarrollar un programa de optimización de uso de estos medicamentos en la institución.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: The irrational use of antimicrobials is a health problem. In "William Soler" Pediatric Cardiocenter there is a wide use of them; however, the behavior of the consumption of this pharmacological group in the institution is not known.  Objective:  To describe the consumption of selected antimicrobials in the institution in the period 2011-2015  Method:  Descriptive, longitudinal study of the use of medicines for the consumption of 11 antimicrobials, of restricted use and high cost (cefepime, meropenem, oral and parenteral levofloxacin, linezolid, teicoplanin, vancomycin, colistin, aztreonam and amoxicillin / oral and parenteral sulbactam). The average consumption in physical units was obtained from the stowage cards of the drug store of the in-hospital pharmacy. For the calculation, the formula established by the World Health Organization was used and this is expressed in a defined daily dose / 100 beds / day (DDD / 100 beds / day).  Results:  An increase of 7.28 DDD / 100 beds / day was observed; the years 2013 and 2015 were shown as those with the highest consumption. The most consumed drugs were meropenem with an increase of 2.71 DD / 100 beds / day; cefepime with an increase of 1.68 DD / 100 beds / day; and linezolid with an increase of 1.15 DDD / 100 beds / day. Therapy room 1 and room 1A showed the highest consumption values.  Conclusions:  Antimicrobials have reduced in a crucial way the threat that infectious diseases represent, and they are also an indispensable tool in the treatment of patients in hospitals. The consumption of selected antimicrobials considered of high cost and restricted use in &#8220;William Soler&#8221; Pediatric Cardiocenter shows a tendency to increase, which shows the need to develop a program to optimize the use of antimicrobials in the institution.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[consumo hospitalario]]></kwd>
<kwd lng="es"><![CDATA[antimicrobianos]]></kwd>
<kwd lng="es"><![CDATA[estudio de utilización de medicamentos]]></kwd>
<kwd lng="en"><![CDATA[hospital consumption]]></kwd>
<kwd lng="en"><![CDATA[antimicrobials, drugs&#8217; use study]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Livermore D]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bacterial resistance Origins, epidemiology, and impact]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2003</year>
<volume>36</volume>
<page-range>11-23</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morales Felipe]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Villa Lorenzo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Pola]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Mella]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolución del consumo de antimicrobianos de uso restringido y tendencia de la susceptibilidad in vitro en el Hospital Regional de Concepción, Chile]]></article-title>
<source><![CDATA[Rev Chilena Infectol]]></source>
<year>2012</year>
<volume>29</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>492-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Baño]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Paño-Pardo]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Rocha]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Asensio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Calbo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cercenado]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles documento de consenso GEIH-SEIMC, SEFH y SEMPSPH]]></article-title>
<source><![CDATA[Enferm Infecc Microbiol Clin]]></source>
<year>2012</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-23</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bidone]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Giglio]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Bakir]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sheehan]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Arias López]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Rosin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescripción y uso de antibióticos en una unidad de cuidados intensivos pediátricos de la Ciudad de Buenos Aires]]></article-title>
<source><![CDATA[Arch Argent Pediatr]]></source>
<year>2008</year>
<volume>106</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>409-15</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vega]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Fontana]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Iturrieta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Segovia]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Agüero]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumo de antimicrobianos en la Unidad de Terapia Intensiva del Hospital Dr Guillermo Rawson-San Juan, Argentina]]></article-title>
<source><![CDATA[Rev Chilena Infectol]]></source>
<year>2015</year>
<volume>32</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>259-65</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tenover]]></surname>
<given-names><![CDATA[F C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mechanisms of antimicrobial resistance in bacteria]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2006</year>
<volume>119</volume>
<numero>6^s1</numero>
<issue>6^s1</issue>
<supplement>1</supplement>
<page-range>3-10</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hutchinson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Patrick]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Marra]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Helen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Bowie]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Heule]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Measurement of antibiotic consumption A practical guide to the use of the Anatomical Therapeutic Chemical classification and Defined Daily Dose system methodology in Canada]]></article-title>
<source><![CDATA[Can J Infect Dis]]></source>
<year>2004</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-35</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Collaborating Centre for Drug Statistics Methodology Guidelines for ATC classification and DDD assignment]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>European Centre for Disease Prevention and Control</collab>
<source><![CDATA[Surveillance of antimicrobial consumption in Europe, 2011]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Stockholm ]]></publisher-loc>
<publisher-name><![CDATA[ECDC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wirtz]]></surname>
<given-names><![CDATA[VJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mol]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Verdijk]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Stichele]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Taxis]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of antibacterial fixed-dose combinations in the private sector in eight Latin American Countries between 1999 and 2009]]></article-title>
<source><![CDATA[Tropical Medicine and International Health]]></source>
<year>2013</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>416-25</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furones]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mederos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cordero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilera]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de los estudios de utilización de medicamentos publicados en revistas médicas cubanas, 1990-2003]]></article-title>
<source><![CDATA[Rev Cub Farm]]></source>
<year>2006</year>
<volume>40</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez-Martínez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[García-Milián]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso-Carbonell]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Rojas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumo de antimicrobianos de uso exclusivo hospitalario Holguín 2008-2012]]></article-title>
<source><![CDATA[Revista Salud Quintana Roo]]></source>
<year>2014</year>
<volume>29</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>21-5</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cruz Barrios]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudios de utilización de medicamentos]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Furones]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Lara]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Barbado]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<source><![CDATA[Farmacoepidemiología. Uso racional de medicamentos]]></source>
<year>2010</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Academia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Candel]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Chiarella]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Picazo]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualización en Patología Infecciosa 2015]]></article-title>
<source><![CDATA[Rev Esp Quimioter]]></source>
<year>2015</year>
<volume>28</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S1-4</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seguro]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Lujan Alovero]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Lamberghini]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumo de antimicrobianos en un hospital privado efecto de un programa para el uso racional]]></article-title>
<source><![CDATA[Rev. Bras. Farm. Hosp. Serv. Saúde São Paulo]]></source>
<year>2013</year>
<volume>4</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>28-34</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ávila]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilera]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Rigo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolución del consumo de antibióticos y resistencia antimicrobiana en un hospital de argentina]]></article-title>
<source><![CDATA[Rev. Bras. Farm. Hosp. Serv. Saúde São Paulo]]></source>
<year>2014</year>
<volume>2</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>8-13</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Collado]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Losa]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Álvaro]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Toro]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación del consumo de antimicrobianos mediante DDD/100 estancias versus DDD/100 altas en la implantación de un Programa de Optimización del Uso de Antimicrobianos]]></article-title>
<source><![CDATA[Rev Esp Quimioter]]></source>
<year>2015</year>
<volume>28</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>317-21</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maortua]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relationship between in-hospital bacterial resistance and antimicrobial use over a 13-year period Sección Microbiología, Hospital Santiago Apóstol, Vitoria-Gasteiz, España]]></article-title>
<source><![CDATA[Enferm Infecc Microbiol Clin]]></source>
<year>2009</year>
<volume>27</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>441-8</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Curcio D]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[On behalf of the Latin American Antibiotic Use in Intensive Care Unit Group Antibiotic prescription in intensive care units in Latin America]]></article-title>
<source><![CDATA[Rev Argent Microbiol]]></source>
<year>2011</year>
<volume>43</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>203-11</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uriol Castillo]]></surname>
<given-names><![CDATA[IE]]></given-names>
</name>
<name>
<surname><![CDATA[Romero Goicochea]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Benítez Castillo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Quispe Díaz]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Zapata]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumo de antimicrobianos de reserva relacionado con su indicación y prescripción en el servicio de cuidados intensivos en adultos del Hospital regional docente de Trujillo]]></article-title>
<source><![CDATA[UCV-Scientia]]></source>
<year>2013</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>70-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Orihuela]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz Salvador]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Alfonso Orta]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Izquierdo Delgado]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Hernández]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso, consumo y costo de medicamentos antimicrobianos controlados en dos servicios del Hospital Universitario "General Calixto García"]]></article-title>
<source><![CDATA[Revista Habanera de Ciencias Médicas]]></source>
<year>2013</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>152-61</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grau]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Fondevilla]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Mojal]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Palomar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vallès]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gudiol]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antibiotic consumption at 46 VINCat hospitals from 2007 to 2009, stratified by hospital size and clinical services]]></article-title>
<collab>VINCat Antimicrobial Group</collab>
<source><![CDATA[Enferm Infecc Microbiol Clin]]></source>
<year>2012</year>
<volume>30</volume>
<numero>^s3</numero>
<issue>^s3</issue>
<supplement>3</supplement>
<page-range>S43-51</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chaverri-Fernández]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Cordero-García]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Madriz]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Moya-Blanco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vega-Brown]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revisión del uso de antibióticos de amplio espectro en el ambiente hospitalario privado en Costa Rica]]></article-title>
<source><![CDATA[Acta Méd Costarric]]></source>
<year>2014</year>
<volume>56</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>158-62</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Tena]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínico-epidemiológicas de pacientes hospitalizados en tratamiento con antibióticos de uso restringido en un hospital de segundo nivel]]></article-title>
<source><![CDATA[Ars Pharm]]></source>
<year>2015</year>
<volume>56</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>161-4</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rosales]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cabello]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bavestrello]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Labarca]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación del consumo de antimicrobianos en 15 hospitales chilenos Resultados de un trabajo colaborativo, 2013]]></article-title>
<source><![CDATA[Rev Chilena Infectol]]></source>
<year>2016</year>
<volume>33</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>307-12</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
